Photo Credit: Yonatan Sindel / Flash 90
Medical worker prepares a COVID-19 vaccine injection, at Clalit COVID-19 vaccination center in Jerusalem, on January 18, 2021.

Israel’s Health Ministry informed the country’s health maintenance organizations (HMOs) that they can begin to administer a third dose of COVID-19 vaccine to adults at medical risk — the first country in the world to do so.

Among those who qualify to receive the booster shot are liver transplant recipients, bone marrow transplant recipients, those with hemoglobinapathy, multiple sclerosis, autoimmune or rheumatological diseases, oncology patients currently receiving chemotherapy treatment and those with primary immune system issues.


The booster shot is being administered because most people who have immunosuppression issues have not developed enough of the necessary antibodies that can neutralize the COVID-19 virus.

The Health Ministry has recommended that those who wish to receive the booster shot wait at least four weeks – and preferably eight weeks – between the second and third dose.

It is also recommended to perform a serological test at least 14 days after the administration of the second dose of vaccine, and before one receives the third shot, the ministry said.

In addition, the ministry recommended that another serological test be performed at 14 days after one receives the third dose. However, medical personnel are cautioned not to administer any further doses, regardless of the results of the test for antibodies.


Previous articleIIBR Partners with NRx Pharmaceuticals to Complete Trials, Manufacture Israel’s ‘BriLife’ Vaccine
Next articleWhy Did the NY Times Deliberately Hide News Of Anti-Semitic Attacks?
Hana Levi Julian is a Middle East news analyst with a degree in Mass Communication and Journalism from Southern Connecticut State University. A past columnist with The Jewish Press and senior editor at Arutz 7, Ms. Julian has written for, and other media outlets, in addition to her years working in broadcast journalism.